Last reviewed · How we verify

Lopinavir and Ritonavir Tablets

DualityBio Inc. · FDA-approved active Small molecule

Lopinavir and Ritonavir Tablets is a HIV protease inhibitor Small molecule drug developed by DualityBio Inc.. It is currently FDA-approved for HIV-1 infection in combination with other antiretroviral agents. Also known as: Kletra.

Lopinavir and ritonavir are HIV protease inhibitors that block the viral protease enzyme, preventing the maturation of HIV particles and reducing viral replication.

Lopinavir and ritonavir are HIV protease inhibitors that block the viral protease enzyme, preventing the maturation of HIV particles and reducing viral replication. Used for HIV-1 infection in treatment-naïve and treatment-experienced patients, HIV-1 infection in combination antiretroviral therapy.

At a glance

Generic nameLopinavir and Ritonavir Tablets
Also known asKletra
SponsorDualityBio Inc.
Drug classHIV protease inhibitor
TargetHIV protease
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

Lopinavir inhibits HIV protease, an enzyme essential for cleaving viral polyproteins into functional components needed for infectious particle assembly. Ritonavir is a potent protease inhibitor that also acts as a pharmacokinetic booster, inhibiting cytochrome P450 metabolism to increase lopinavir plasma concentrations. Together, they suppress HIV replication and reduce viral load in infected patients.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lopinavir and Ritonavir Tablets

What is Lopinavir and Ritonavir Tablets?

Lopinavir and Ritonavir Tablets is a HIV protease inhibitor drug developed by DualityBio Inc., indicated for HIV-1 infection in combination with other antiretroviral agents.

How does Lopinavir and Ritonavir Tablets work?

Lopinavir and ritonavir are HIV protease inhibitors that block the viral protease enzyme, preventing the maturation of HIV particles and reducing viral replication.

What is Lopinavir and Ritonavir Tablets used for?

Lopinavir and Ritonavir Tablets is indicated for HIV-1 infection in combination with other antiretroviral agents.

Who makes Lopinavir and Ritonavir Tablets?

Lopinavir and Ritonavir Tablets is developed and marketed by DualityBio Inc. (see full DualityBio Inc. pipeline at /company/dualitybio-inc).

Is Lopinavir and Ritonavir Tablets also known as anything else?

Lopinavir and Ritonavir Tablets is also known as Kletra.

What drug class is Lopinavir and Ritonavir Tablets in?

Lopinavir and Ritonavir Tablets belongs to the HIV protease inhibitor class. See all HIV protease inhibitor drugs at /class/hiv-protease-inhibitor.

What development phase is Lopinavir and Ritonavir Tablets in?

Lopinavir and Ritonavir Tablets is FDA-approved (marketed).

What are the side effects of Lopinavir and Ritonavir Tablets?

Common side effects of Lopinavir and Ritonavir Tablets include Diarrhea, Nausea, Abdominal pain, Headache, Lipid abnormalities (elevated cholesterol/triglycerides), Hepatotoxicity.

What does Lopinavir and Ritonavir Tablets target?

Lopinavir and Ritonavir Tablets targets HIV protease and is a HIV protease inhibitor.

Related